IQ-AI Limited Exercise of Options (6137Z)
13 Enero 2020 - 5:35AM
UK Regulatory
TIDMIQAI
RNS Number : 6137Z
IQ-AI Limited
13 January 2020
IQ-AI Ltd
("IQ-AI" or the "Company")
Exercise of Options
IQ-AI Ltd, the parent company of StoneChecker(R) and Imaging
Biometrics(R), announces that it has issued 1,000,000 ordinary
shares in the Company of par value GBP0.01 ("Ordinary Shares")
following the exercise of options ("Options") over Ordinary Shares
as summarised below.
The Options have been exercised by David Smith. Mr Smith's
contract as CEO of StoneChecker and Imaging Biometrics, the
Company's subsidiaries, expired on 31(st) December 2019. Mr Smith
is now a consultant to the Company.
The Options were issued as part of David Smith's employment
contract. He has exercised 1,000,000 Ordinary Shares at GBP0.026
each, totalling GBP26,000 cash.
Admission and Total Voting Rights
Pursuant to the exercise of the Options, application will be
made for 1,000,000 new Ordinary Shares, which will rank pari passu
with existing Ordinary Shares, to be admitted to the standard
segment of the Main Market ('Admission'). It is expected that
Admission will become effective and dealings will commence at
8:00am on or around 16 January 2020.
Following Admission, the total issued share capital of the
Company will consist of 140,830,982 Ordinary Shares. As such, the
total number of voting rights in the Company will be 140,830,982
Ordinary Shares. This number may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest, or a change to their
interest in, the Company under the FCA's Disclosure and
Transparency Rules.
Regulatory Information
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
The Directors of the Company accept responsibility for the
contents of this announcement.
-ENDS-
For further information, please contact:
IQ-AI Limited
Trevor Brown/Vinod Kaushal/Qu Li
Tel: 020 7469 0930
----------------------------------------------------------
Peterhouse Capital Limited (Financial Adviser and Broker)
Lucy Williams/Heena Karani
Tel: 020 7220 9797
----------------------------------------------------------
About IQ-AI Ltd
IQ-AI, Ltd, the parent company of StoneChecker(R) and Imaging
Biometrics(R), is focused on advanced and state of the art medical
software and services. (IQ-AI.ltd). Imaging Biometrics develops and
provides visualization and analytical solutions that enable
clinicians to better diagnose and treat diseases with greater
confidence. Through close collaboration with researchers and
clinicians, sophisticated advancements are translated into
platform-independent software plug-ins which can extend the base
functionality of workstations, imaging systems, PACS, or medical
viewers. By design, IB's advanced visualization software seamlessly
integrates into routine workflows. Please visit
www.imagingbiometrics.com for further information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
IOEKKNBBDBKDPDD
(END) Dow Jones Newswires
January 13, 2020 06:35 ET (11:35 GMT)
Iq-ai (LSE:IQAI)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Iq-ai (LSE:IQAI)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024